Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Pyridines and derivatives
  7. Nalidixic acid sodium salt, 98.1%, MP Biomedicals™

Nalidixic acid sodium salt, 98.1%, MP Biomedicals™

Catalog No. ICN15172405 Shop All MP Biomedicals, Inc Products
Change view
Click to view available options
Quantity:
1 g
5 g
25 g
100 g
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
ICN15172405 5 g
ICN15172401 1 g
ICN15172425 25 g
ICN15172480 100 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Catalog No. ICN15172405 Supplier MP Biomedicals, Inc Supplier No. 0215172405
Only null left
Add to Cart
Add to Cart

Chemical Identifiers

CAS 389-08-2
Molecular Formula C12H12N2O3
Molecular Weight (g/mol) 232.239
InChI Key MHWLWQUZZRMNGJ-UHFFFAOYSA-N
Synonym nalidixic acid, nalidixin, nevigramon, nalidixate, uronidix, innoxalon, nalidixan, nalitucsan, sicmylon, unaserus
PubChem CID 4421
ChEBI CHEBI:100147
IUPAC Name 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
SMILES CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O

Specifications

Color White
Assay Percent Range ∽ 98%
Quantity 5 g
Formula Weight 254.2
Physical Form Powder
Chemical Name or Material Nalidixic Acid Sodium Salt

Safety and Handling

storageNote1 Use only in area provided with appropriate exhaust ventilation
Recommended Storage Store at 0°C.
WARNING: Cancer - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.